Phase II clinical trial results presented at the American Academy of Dermatology 2019 Annual Meeting

Dr. Stacy R. Smith presented an abstract entitled – “Successful Treatment of Common Warts with Candida Extract – a Phase II study” at the Annual Meeting of the American Academy of Dermatology in Washington DC. Read More – Candida albicans Skin Test Antigen for Cellular Hypersensitivity has not been proven safe and effective for use in warts. Nielsen BioSciences intends to pursue FDA approval in the near future.

The release as fetched from its publisher. nielsenbio.com ↗